Compare Mutual Funds
Motilal Oswal Nifty MidSmall Healthcare Index Fund
EquitySectoral-Pharma
Select a Mutual Fund
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹500
-
Expense Ratio
1.22
-
NAV
₹11.68
-
Fund Started
29 Oct 2024
-
Fund Size
₹52.54 Cr
-
Exit Load
Exit load of 1%, if redeemed within 15 days.
-
1 Year
7.93%
-
3 Year
-
-
5 Year
-
-
Equity
100.07%
-
Cash
-0.07%
-
Top 10 Holdings
Name | Assets |
|---|---|
Laurus Labs Ltd. | 11.83% |
Lupin Ltd. | 7.57% |
Aurobindo Pharma Ltd. | 7.09% |
Fortis Healthcare Ltd. | 6.15% |
Glenmark Pharmaceuticals Ltd. | 5.39% |
Alkem Laboratories Ltd. | 4.78% |
Mankind Pharma Ltd. | 4.35% |
Ipca Laboratories Ltd. | 4.11% |
Biocon Ltd. | 3.96% |
Gland Pharma Ltd. | 3.54% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
-
Launch Date
29 Oct 2024
-
